HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCPC Sits Down With HBW Insight: Preemption, California Latest, Microbeads In China, More

Executive Summary

In a pause from the trade group’s 2020 annual meeting in Palm Beach, FL, PCPC senior executives spoke with HBW Insight about legislative priorities and challenges at the federal and state levels, emerging microplastic regulations and whether industry and consumers have a “trust problem.”

You may also be interested in...



Cosmetics Industry Still Committed To Reg Modernization, But FDA User-Fee Reauthorization May Not Be Vehicle

A “clean” FDA user-fee reauthorization bill – minus cosmetics modernization provisions – could be the likeliest way forward with user-fee program funding set to elapse at the end of September, a PCPC rep suggested in an email to HBW Insight.

US Cosmetics Reform Bill Would Require FDA Regulation Of ‘Natural’ Labeling

Beautycounter and Burt’s Bees are among the most vocal companies pushing for modernization of US cosmetics regulations via the proposed Personal Care Products Safety Act, which would require the FDA to establish a “natural” definition for use in product labeling.

PCPC: Beauty Industry Getting Wrapped Up In Sustainable Packaging

Already focused on driving innovation through the Sustainable Packaging Initiative for Cosmetics, the beauty and personal-care industry expects to face increased stakeholder and government pressure in 2021 regarding packaging impacts on the environment. Personal Care Products Council leaders discuss.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS149812

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel